These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 9049785

  • 1. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
    Shi M, Taylor JM, Fahey JL, Hoover DR, Muñoz A, Kingsley LA.
    J Clin Immunol; 1997 Jan; 17(1):43-52. PubMed ID: 9049785
    [Abstract] [Full Text] [Related]

  • 2. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV.
    N Engl J Med; 1990 Jan 18; 322(3):166-72. PubMed ID: 1967191
    [Abstract] [Full Text] [Related]

  • 3. Tracking of markers and onset of disease among HIV-1 seroconverters.
    Galai N, Muñoz A, Chen K, Carey VJ, Chmiel J, Zhou SY.
    Stat Med; 1993 Nov 30; 12(22):2133-45. PubMed ID: 7906051
    [Abstract] [Full Text] [Related]

  • 4. Dependence of the hazard of AIDS on markers.
    Yong FH, Taylor JM, Bryant JL, Chmiel JS, Gange SJ, Hoover D.
    AIDS; 1997 Feb 30; 11(2):217-28. PubMed ID: 9030370
    [Abstract] [Full Text] [Related]

  • 5. A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.
    Briggs NC, Natoli C, Tinari N, D'Egidio M, Goedert JJ, Iacobelli S.
    AIDS Res Hum Retroviruses; 1993 Sep 30; 9(9):811-6. PubMed ID: 7504933
    [Abstract] [Full Text] [Related]

  • 6. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
    Krämer A, Biggar RJ, Hampl H, Friedman RM, Fuchs D, Wachter H, Goedert JJ.
    Am J Epidemiol; 1992 Jul 01; 136(1):71-80. PubMed ID: 1384311
    [Abstract] [Full Text] [Related]

  • 7. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
    Whittle H, Egboga A, Todd J, Corrah T, Wilkins A, Demba E, Morgan G, Rolfe M, Berry N, Tedder R.
    AIDS; 1992 Jul 01; 6(7):685-9. PubMed ID: 1354448
    [Abstract] [Full Text] [Related]

  • 8. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F, Labarga P, Pinilla J, Soto MJ, Leoz A, del Cura J, Borque L, Milazzo A.
    Enferm Infecc Microbiol Clin; 1993 Jul 01; 11(7):373-7. PubMed ID: 8104488
    [Abstract] [Full Text] [Related]

  • 9. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
    Krown SE, Niedzwiecki D, Bhalla RB, Flomenberg N, Bundow D, Chapman D.
    J Acquir Immune Defic Syndr (1988); 1991 Jul 01; 4(9):871-80. PubMed ID: 1895208
    [Abstract] [Full Text] [Related]

  • 10. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J.
    BMJ; 1991 Jan 12; 302(6768):73-8. PubMed ID: 1671651
    [Abstract] [Full Text] [Related]

  • 11. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study.
    Shi M, Taylor JM, Currier RJ, Tang H, Hoover DR, Chmiel JS, Bryant JL.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul 12; 12(3):309-16. PubMed ID: 8673537
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
    Farzadegan H, Henrard DR, Kleeberger CA, Schrager L, Kirby AJ, Saah AJ, Rinaldo CR, O'Gorman M, Detels R, Taylor E, Phair JP, Margolick JB.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec 15; 13(5):448-55. PubMed ID: 8970472
    [Abstract] [Full Text] [Related]

  • 15. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
    Planella T, Cortés M, Martínez-Brú C, Barrio J, Sambeat MA, González-Sastre F.
    Clin Chem Lab Med; 1998 Mar 15; 36(3):169-73. PubMed ID: 9589805
    [Abstract] [Full Text] [Related]

  • 16. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.
    Hofmann B, Wang YX, Cumberland WG, Detels R, Bozorgmehri M, Fahey JL.
    AIDS; 1990 Mar 15; 4(3):207-14. PubMed ID: 1972020
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
    Mellors JW, Kingsley LA, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P.
    Ann Intern Med; 1995 Apr 15; 122(8):573-9. PubMed ID: 7887550
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
    Siller L, Martin NL, Kostuchenko P, Beckett L, Rautonen J, Cheng SC, Wara DW.
    AIDS; 1993 Mar 15; 7(3):369-73. PubMed ID: 8097095
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2',3'-dideoxyinosine (ddI).
    Reddy MM, McKinley GF, Grieco MH.
    J Clin Lab Anal; 1991 Mar 15; 5(6):396-8. PubMed ID: 1774603
    [Abstract] [Full Text] [Related]

  • 20. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
    Zangerle R, Steinhuber S, Sarcletti M, Dierich MP, Wachter H, Fuchs D, Möst J.
    Int Arch Allergy Immunol; 1998 Jul 15; 116(3):228-39. PubMed ID: 9693271
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.